DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ozarelix
Ozarelix
(12) United States Patent (10) Patent No.: US 9,682,960 B2 Labrie Et Al
WO 2018/144603 Al 09 August 2018 (09.08.2018) W !P O PCT
Spectrum Pharmaceuticals Initiates US Clinical
View Annual Report
Spectrum Announces Completion of Patient Enrollment in Ozarelix Phase II Trial in Patients with Benign Prostatic Hypertrophy
(12) Patent Application Publication (10) Pub. No.: US 2010/0190692 A1 VAN GROENINGHEN (43) Pub
(12) United States Patent (10) Patent No.: US 8,853,266 B2 Dalton Et Al
Adis R&D Insight
A61p5/28 (2006.01)
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
PEPTIDES in CANCER RESEARCH Cancer Research
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
(10) Patent No.: US 8080682 B2
Management of Endometriosis:An Enigmatic Disease
Urotoday International Journal
New Considerations for ADT in Advanced Prostate Cancer and the Emerging Role of Gnrh Antagonists
Who Expert Committee on Specifications for Pharmaceutical Preparations
Top View
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Management of Endometriosis: an Enigmatic Disease
Management of Biochemically Recurrent Prostate Cancer Following Local Therapy
Luteinizing Hormone-Releasing Hormone Antagonists
Pharmaabkommen A1 E
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
ABSTRACTS of the 20Th ANNUAL MEETING of the ITALIAN SOCIETY of URO-ONCOLOGY (Siuro)
(12) Patent Application Publication (10) Pub. No.: US 2014/0199236A1 CHEN Et Al
Causes of Chronic Pelvic Pain
Advances in Therapeutic Peptides Targeting G Protein-Coupled Receptors
― D06 - 1 ― 医学中央雑誌刊行会・医学用語シソーラス 第9版( 2019) カテゴリー別リスト
Use of LHRH Antagonists in Combination with PDE V Inhibitors for the Treatment of Sex Hormone Dependent Disorders
Cancer PRESENTEDBYAMERICA ’ SBIOPHARMACEUTICALRESEARCHCOMPANIES Nearly 900 Medicines and Vaccines in Testing Offer Hope in the Fight Against Cancer
Medicines & Vaccines in Development for Cancer
Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions
WO 2010/032200 Al
Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer
Advances in Hormonal Therapies for Hormone Naïve and Castration‑Resistant Prostate Cancers with Or Without Previous Chemotherapy Thy Pham1, Martin C
Questions LHRH Antagonists
Development and Validation of a Reversed-Phase HPLC Method for Assay of the Decapeptide Cetrorelix Acetate in Bulk and Pharmaceutical Dosage Forms
EP2945628B1.Pdf
Molecular Approaches to Target Gpcrs in Cancer Therapy